Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with polycythemia vera (PV).

被引：0

作者：

Rinaldi, Ciro

Rein, Lindsay

Livings, Alice

Innes, Andrew J.

Pettit, Kristen

Yeh, Paul

Larsen, Stephen R.

Watson, Anne-Marie

Leahy, Michael F.

Curto-Garcia, Natalia

Mahdi, Ali

Frewin, Rebecca

Qureshi, Haifz

Shatzel, Joseph

Vaughn, Jennifer

Tashi, Tsewang

Amin, Harshad

Ogbu, Uzor

Gumuscu, Burak

Ross, David M.

机构：

[1] United Lincolnshire Hosp Trust, Lincoln, England

[2] Univ Lincoln, Lincoln, England

[3] Duke Canc Inst, Durham, NC USA

[4] Montserrat Canc Care, Sunshine Coast Haematol & Oncol Clin, Buderim, Qld, Australia

[5] Imperial Coll Healthcare NHS Trust, London, England

[6] Univ Michigan, Ann Arbor, MI USA

[7] Monash Hlth, Clayton, Vic, Australia

[8] Monash Univ, Clayton, Vic, Australia

[9] Univ Sydney, Camperdown, NSW, Australia

[10] Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[11] Liverpool Hosp, Liverpool, NSW, Australia

[12] Univ Western Australia, Royal Perth Hosp, Perth, Australia

[13] Guys & St Thomas NHS Fdn Trust, London, England

[14] Aneurin Bevan Univ Hlth Board, Newport, England

[15] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England

[16] Univ Hosp Leicester NHS Trust, Leicester, England

[17] Oregon Hlth & Sci Univ, Portland, OR USA

[18] Ohio State Univ, Coll Med, Columbus, OH USA

[19] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[20] Mem Healthcare Syst, Plantation, FL USA

[21] Merck & Co Inc, Rahway, NJ USA

[22] Royal Adelaide Hosp, Adelaide, Australia

[23] SA Pathol, Adelaide, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS6595

引用

页数：1

共 50 条

[41] Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma
Wei, Xiaomu
Calvo-Vidal, M. Nieves
Chen, Siwei
Wu, Gang
Revuelta, Maria V.
Sun, Jian
Zhang, Jinghui
Walsh, Michael F.
Nichols, Kim E.
Joseph, Vijai
Snyder, Carrie
Vachon, Celine M.
Mckay, James D.
Wang, Shu-Ping
Jayabalan, David S.
Jacobs, Lauren M.
Becirovic, Dina
Waller, Rosalie G.
Artomov, Mykyta
Viale, Agnes
Patel, Jayeshkumar
Phillip, Jude
Chen-Kiang, Selina
Curtin, Karen
Salama, Mohamed
Atanackovic, Djordje
Niesvizky, Ruben
Landgren, Ola
Slager, Susan L.
Godley, Lucy A.
Churpek, Jane
Garber, Judy E.
Anderson, Kenneth C.
Daly, Mark J.
Roeder, Robert G.
Dumontet, Charles
Lynch, Henry T.
Mullighan, Charles G.
Camp, Nicola J.
Offit, Kenneth
Klein, Robert J.
Yu, Haiyuan
Cerchietti, Leandro
Lipkin, Steven M.
CANCER RESEARCH, 2018, 78 (10) : 2747 - 2759
[42] Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene
Zhu, Qingjun
Liu, Cheng
Ge, Zheng
Fang, Xiaolei
Zhang, Xi
Straat, Klas
Bjorkholm, Magnus
Xu, Dawei
PLOS ONE, 2008, 3 (01):
[43] The Epigenetic Controller Lysine-Specific Demethylase 1 (LSD1) Regulates the Outcome of Hepatitis C Viral Infection
Papadopoulou, Georgia
Petroulia, Stavroula
Karamichali, Eirini
Dimitriadis, Alexios
Marousis, Dimitrios
Ioannidou, Elisavet
Papazafiri, Panagiota
Koskinas, John
Foka, Pelagia
Georgopoulou, Urania
CELLS, 2023, 12 (21)
[44] Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis
Qunyan Sun
Ding Ding
Xishi Liu
Sun-Wei Guo
Reproductive Biology and Endocrinology, 14
[45] Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc
Nagasaka, Mai
Tsuzuki, Kaori
Ozeki, Yu
Tokugawa, Muneshige
Ohoka, Nobumichi
Inoue, Yasumichi
Hayashi, Hidetoshi
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 481 - 488
[46] A phase I, open-label, study of GSK2879552, a lysine-specific demethylase 1 (LSD1) inhibitor, in patients with relapsed/refractory small cell lung carcinoma (SCLC)
Moreno, V.
Bauer, T. M.
Infante, J.
Govindan, R.
Besse, B.
Bertino, E.
Martinez Marti, A.
Piontek, T.
Dhar, A.
ANNALS OF ONCOLOGY, 2016, 27
[47] A Phase 2a Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Myelofibrosis
Pettit, Kristen
Gerds, Aaron T.
Yacoub, Abdulraheem
Watts, Justin M.
Tartaczuch, Maciej
Bradley, Terrence J.
Shortt, Jake
Stevenson, William S.
Curtin, Natasha Joan
Rossetti, James M.
Burbury, Kate
Natsoulis, Georges
Jones, Amber
Talpaz, Moshe
Peppe, Jennifer
Ross, David M.
Rienhoff, Hugh Young, Jr.
BLOOD, 2019, 134
[48] INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1A (LSD1) SUPPORTS HUMAN HSCS IN CULTURE BY PRESERVING THEIR IMMATURE STATE
Subramaniam, Agatheeswaran
Zemaitis, Kristijonas
Talkhoncheh, Mehrnaz Safaee
Debnath, Shubhranshu
Chen, Jun
Jain, Mayur
Galeev, Roman
Larsson, Jonas
EXPERIMENTAL HEMATOLOGY, 2019, 76 : S87 - S87
[49] Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
Amente, Stefano
Milazzo, Giorgio
Sorrentino, Maria Cristina
Ambrosio, Susanna
Di Palo, Giacomo
Lania, Luigi
Perini, Giovanni
Majello, Barbara
ONCOTARGET, 2015, 6 (16) : 14572 - 14583
[50] Lysine-specific demethylase 1 (LSD1) suppresses cellular senescence by riboflavin uptake-dependent demethylation activity
Osumi, Taiichi
Nagano, Taiki
Iwasaki, Tetsushi
Nakanishi, Jotaro
Miyazawa, Kazuyuki
Kamada, Shinji
SCIENTIFIC REPORTS, 2025, 15 (01):

← 1 2 3 4 5 →